Effects of sodium intake on the pressor and renal responses to nitric oxide synthesis inhibition in normotensive individuals with different sodium sensitivity

Journal of Hypertension

Volumn 18, Issue 5, 2000, Pages 615-621

  Barba, Gianvincenzo ^a   Vallance, Patrick J ^c   Strazzullo, Pasquale ^b   MacAllister, Raymond J ^c  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NONE

Author keywords

Blood pressure; Diet; N(G)monomethyl L arginine; Nitric oxide; Renal function; Sodium; Sodium dependent hypertension

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL TONE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SODIUM EXCRETION; SODIUM INTAKE; SODIUM RESTRICTION; SYSTEMIC VASCULAR RESISTANCE; URINE FLOW RATE;

EID: 0034024393     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018050-00015     Document Type: Article

References (42)

1. 1 Denton D, Wesinger R, Mundy NY, et al. The effect of increased salt intake on blood pressure of chimpanzees. Nature Med 1995; 1:1009-1016.
2. 2 Intersalt Cooperative Research group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium. BMJ 1988; 297:319-328.
3. 3 Cutler J, Follman D, Elliott P, Suh I. An overview of randomised trials of sodium reduction and blood pressure. Hypertension 1991; 17 (suppl 1):27-33.
4. 4 Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA. Arterial pressure regulation. Am J Med 1972; 52:584-591.
5. 5 Sullivan JM, Ratts TE. Hemodynamic mechanisms of adaptation to chronic high sodium intake in normal humans. Hypertension 1983; 5:814-820.
6. +)-ATPase inhibitors in hypertension. Hypertension 1991; 17:830-836.
7. 7 Brown WJ JR, Brown FK, Krishan I. Exchangeable sodium and blood volume in normotensive and hypertensive humans on high and low sodium intake. Circulation 1971; 43:508-519.
8. 8 Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure: age and pressure change over time. J Hypertens 1992; 10:1089-1094.
9. 9 Galletti F, Ferrara I, Stinga F, Sacchi A, Barba G, Iacone R, et al. Effect of intravenous sodium chloride on renal sodium and calcium handling in hypertensive patients with different sensitivities to sodium chloride. J Hypertens 1993; 11 (suppl 5):S194-S195.
10. 10 Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8 (suppl II):II127-II134.
11. 11 Miller JZ, Weinberger MH, Daugherty SA, Fineberg NS, Christian JC, Grim CE. Heterogeneity of blood pressure response to dietary sodium restriction in normotensive adults. J Chronic Dis 1987; 40:245-250.
12. 12 Sharma AM. Schattenfroh S, Kribben A, Distler A. Reliability of salt-sensitivity testing in normotensive subjects. Klin W 1989; 67:632-634.
13. 13 Galletti F, Ferrara I, Stinga F, Iacone R, Noviello F, Strazzullo. Evaluation of a rapid protocol for the assessment of salt sensitivity against the blood pressure response to dietary sodium chloride restriction. Am J Hypertens 1997; 10:462-466.
14. 14 Muntzel M, Druke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens 1992; 5:1S-42S.
15. 15 Barba G, Cappuccio FP, Russo L, Stinga F, Iacone R, Strazzullo P. Renal function and blood pressure response to dietary salt restriction in normotensive men. Hypertension 1996; 27:1160-1164.
16. 16 Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 1994; 23:531-550.
17. 17 Parmer RJ, Stone RA, Cervenka JH. Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium. Hypertension 1994; 24:752-757.
18. 18 Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2:997-1000.
19. 19 MacAllister RJ, Vallance P. Systemic vascular adaptation to increases in blood volume: the role of the blood-vessel wall. Nephrol Dial Trans 1996; 11:231-240.
20. 20 Ruilope LM, Lahera V, Rodicio JL, Romero JC. Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens 1994; 12:625-631.
21. 21 Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991; 80:183-190.
22. 22 Bech JN, Nielsen CB, Pedersen EB. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans. Am J Physiol 1996; 270:F845-F851.
23. 23 Vallance P. Exploring vascular nitric oxide in health and disease. The Goulstonian Lecture. JR Coll Physicians 1997; 31:321-327.
24. 24 MacAllister RJ, Vallance P. Endogenous inhibitors of nitric oxide synthesis: how important are they? Exp Nephrol 1998; 6:195-199.
25. 25 Palmer MJ, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of the nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153:1251-1256.
26. 26 Raij L, Baylis C. Glomerular actions of nitric oxide. Kidney Int 1995; 48:20-32.
27. 27 Nakamura T, Alberola AM, Granger JP. Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide. Hypertension 1993; 21:956-960.
28. 28 Fenoy FJ, Ferrer P, Carbonell L, Garcia-Salom M. Role of nitric oxide on papillary blood flow and pressure natriuresis. Hypertension 1995; 25:408-414.
29. 29 Alberola A, Pinilla JM, Quesada T, Romero JC, Salom MG, Salazar FJ. Role of nitric oxide in mediating renal response to volume expansion. Hypertension 1992; 19:780-784.
30. 30 Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol 1998; 274:F914-F923.
31. 31 Matsuoka H, Itoh S, Kimoto M, Kohno K, Tamai O, Wada Y, et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997; 29:242-247.
32. 32 Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-575.
33. 33 Roddie IC, Wallace WFM. Analysis of serial measurements in medical research. BMJ 1990; 300:230-235.
34. 34 Luft FC. Salt and hypertension at the close of the millennium. Wien Klin Wochenschr 1998; 110:459-466.
35. 35 Strojek K, Grzeszczak W, Gorska J, Keller CK, Ritz E. Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria. Diabetologica 1995; 38:1443-1448.
36. 36 Bigazzi R, Bianchi S, Baldari G, Campese VM. Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin. Am J Hypertens 1996; 9:24-32.
37. 37 Qiu C, Baylis C. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition. Kidney Int 1999; 55:2390-2396.
38. 38 Turkstra E, Braam B, Koomans HA. Losartan attenuates modest but not strong renal vasoconstrictioninduced by nitric oxide inhibition. J Cardiovasc Pharmacol 1998; 32:593-600.
39. 39 Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertension 1993; 11:1375-1380.
40. 40 Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA.Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89:2035-2040.
41. 41 Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88:1559-1567.
42. 42 Patel A, Layne S, Watts D, Kirchner KA. L-arginine administration normalises pressure natriuresis in hypertensive Dahl rats. Hypertension 1993; 22:863-869.